Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer. Academic Article uri icon

Overview

publication date

  • November 30, 2021

Identity

PubMed Central ID

  • PMC8713741

Scopus Document Identifier

  • 85107151318

Digital Object Identifier (DOI)

  • 10.1093/noajnl/vdab178

PubMed ID

  • 34988456

Additional Document Info

volume

  • 3

issue

  • 1